Estimating resource use and cost of prophylactic management of neutropenia with filgrastim. [electronic resource]
Producer: 20050620Description: 265-74 p. digitalISSN:- 0966-0429
- Ambulatory Care -- economics
- Attitude of Health Personnel
- Belgium
- Chemoprevention -- economics
- Cost Savings
- Cost of Illness
- Cost-Benefit Analysis
- Direct Service Costs -- statistics & numerical data
- Drug Costs -- statistics & numerical data
- Filgrastim
- Granulocyte Colony-Stimulating Factor -- economics
- Health Care Costs -- statistics & numerical data
- Health Resources -- economics
- Health Services Research
- Home Care Services -- economics
- Hospital Costs -- statistics & numerical data
- Hospitals, University -- economics
- Humans
- Monte Carlo Method
- Neutropenia -- economics
- Personnel, Hospital -- economics
- Recombinant Proteins
- Sensitivity and Specificity
- Surveys and Questionnaires
- Time and Motion Studies
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.